Hapoalim Cutting Ocverage On Multitude Of Names
Symbols: ACOR, ALKS, AMLN, AMRN, ARNA, AUXL, BMY, BSTC, CEPH, LLY, MDVN, MNKD, MRK, NBIX, NKTR, PFE, PLX, TRGT, VNDA
Tags: Hapoalim Securities
Posted in: Analyst Color, Analyst Ratings
Hapoalim Securities announced it would be terminating coverage of a slew of pharmaceutical names due to an analyst departure.
The names affected are Bristol-Myers (NYSE: BMY), Eli Lilly (NYSE: LLY) Merck (NYSE: MRK) Pfizer (NYSE: PFE) Acorda (NASDAQ: ACOR), Alkermes (NASDAQ: ALKS) Amarin (NASDAQ: AMRN) Amylin (NASDAQ: AMLN) Arena Pharmaceuticals (NASDAQ: ARNA), Auxilium (NASDAQ: AUXL), Biospecifics (NASDAQ: BSTC), Cephalon (NASDAQ: CEPH), MannKind (NASDAQ: MNKD), Medivation (NASDAQ: MDVN), Nektar (NASDAQ: NKTR), Neurocrine Biosciences (NASDAQ: NBIX), Protalix (NYSE: PLX) Targacept (NASDAQ: TRGT), and Vanda Pharmaceuticals (NASDAQ: VNDA).
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
